Aspirin and Acetaminophen Show Potential in Easing MS Fatigue

Recent research indicates that common fever medications, such as aspirin and acetaminophen, may offer benefits to individuals with multiple sclerosis (MS) by easing fatigue and enhancing exercise capacity. These findings emerge from a systematic review and meta-analysis conducted by Ismail A Ibrahim et al., which evaluated the effects of these medications on MS-related symptoms.
The review analyzed 57 reports and included seven studies, revealing that aspirin pretreatment significantly improved time to exhaustion in heat-sensitive MS patients. Additionally, aspirin reduced the post-exercise body temperature rise by 56% in one trial, though this result was not statistically significant in another.
A phase-3 randomized controlled trial led by Leavitt et al. in 2024 further examined the effects of these medications. The trial found that aspirin significantly reduced exercise-induced body temperature increases, while acetaminophen also demonstrated a reduction, albeit less pronounced. However, neither medication significantly improved time to exhaustion compared to a placebo.
Despite mixed results on exercise capacity, aspirin consistently showed benefits across secondary outcomes, including reductions in fatigue, pain, and perceived exertion. These findings suggest potential therapeutic roles for these medications in managing MS symptoms, particularly in regulating body temperature during exercise.